Johnson & Johnson reported smaller compensation packages for three top executives and disclosed pay for new medical device leader Tim Schmid.
Johnson & Johnson MedTech (NYSE: JNJ) announced new regulatory nods for multiple orthopedic technology offerings.
Johnson & Johnson said that its mid-stage study of icotrokinra, for the treatment of moderate to severe active ulcerative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback